Get the Stockscreener App
45.41
1.62%
-0.748
After Hours:
45.35
-0.0606
-0.13%
Global X Genomics Biotechnology Etf stock is traded at $45.41, with a volume of 5,888.
It is down -1.62% in the last 24 hours and down -4.14% over the past month.
See More
Previous Close:
$46.16
Open:
$46.2
24h Volume:
5,888
Relative Volume:
0.56
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.68%
1M Performance:
-4.14%
6M Performance:
+27.56%
1Y Performance:
+18.53%
1-Day Range:
$45.03
$46.20
1-Week Range:
$45.03
$46.90
52-Week Range:
$27.20
$51.42
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
45.41 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.01 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
272.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.64 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
5 Small-cap Biotech ETFs to Watch - Investing News Network
Entravision Communications (NYSE:EVC) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Lakeland Financial (NASDAQ:LKFN) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
German American Bancorp (NASDAQ:GABC) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
AlTi Global (NASDAQ:ALTI) Shares Pass Above Two Hundred Day Moving Average – What’s Next? - Defense World
Demand Brands (OTCMKTS:DMAN) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Mercury General (NYSE:MCY) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Riverview Bancorp (NASDAQ:RVSB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Infrastructure Stocks To Follow Today – February 8th - Defense World
IBBQ, GNOM, BIB: Gain Exposure to Healthcare Startups with Biotech ETFs - TipRanks
Chimerix Shares Approach Peak on Partner’s Rosy Forecast - AD HOC NEWS
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Best Biotech ETFs to Buy in 2026 - The Motley Fool
How (GNOM) Movements Inform Risk Allocation Models - Stock Traders Daily
Trading Systems Reacting to (GNOM) Volatility - Stock Traders Daily
Moderna (MRNA) Stock Surge Boosts ETFs with High Exposure - GuruFocus
Moderna’s rally ripples through biotech and health care ETFs - Seeking Alpha
The Next Big Theme: January 2026 - Global X ETFs
Short Interest in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Expands By 23.3% - Defense World
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
FengHe Fund Management Pte. Ltd. Invests $36.48 Million in Ciena Corporation $CIEN - Defense World
Invesco BulletShares 2025 Corporate Bond ETF $BSCP Shares Bought by Farnam Financial LLC - Defense World
Schwab US Large-Cap ETF $SCHX is Farnam Financial LLC’s Largest Position - Defense World
FengHe Fund Management Pte. Ltd. Invests $49.61 Million in Analog Devices, Inc. $ADI - Defense World
Clarity Wealth Advisors LLC Has $9.09 Million Stock Position in JPMorgan Core Plus Bond ETF $JCPB - Defense World
Vanguard Small-Cap ETF $VB Shares Acquired by Farnam Financial LLC - Defense World
Vanguard FTSE Developed Markets ETF $VEA Shares Bought by Farnam Financial LLC - Defense World
Here's Why Biotech ETFs Are Rallying Hard - Nasdaq
How to Buy CRISPR Therapeutics Stock (CRSP) - The Motley Fool
Allspring Global Investments Holdings LLC Sells 1,180,416 Shares of Alight, Inc. $ALIT - Defense World
(GNOM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Archford Capital Strategies LLC Sells 21,216 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Armbruster Capital Management Inc. Has $54.56 Million Holdings in Vanguard U.S. Value Factor $VFVA - Defense World
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Global X FundsGlobal X Genomics & Biotechnology ETF announces Semi-Annual dividend, payable on January 07, 2026 - marketscreener.com
Acacia Research (NASDAQ:ACTG) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
The Next Big Theme: December 2025 - Seeking Alpha
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
Touchstone Climate Transition ETF (OTCMKTS:HEAT) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
Liquidity Mapping Around (GNOM) Price Events - Stock Traders Daily
Flow Traders U.S. LLC Buys 82,063 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Flow Traders U.S. LLC Has $1.71 Million Position in Avantis Short-Term Fixed Income ETF $AVSF - Defense World
Mateon Therapeutics (OTCMKTS:MATN) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Biglari (NYSE:BH) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Tema Oncology ETF (CANC) Passes $100m AUM, Among Top 3 2025 Healthcare ETFs - Stock Titan
The Next Big Theme: November 2025 - Global X ETFs
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):